Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠

Abstract Background Sickle Cell Disease (SCD) causes profound suffering and decrements in daily functioning. Demand is growing for valid and reliable measures to systematically document these effects, particularly in adults. The Adult Sickle Cell Quality of Life Measurement System, ASCQ-Me℠, was dev...

Full description

Bibliographic Details
Main Authors: San Keller, Manshu Yang, Marsha J. Treadwell, Kathryn L. Hassell
Format: Article
Language:English
Published: BMC 2017-06-01
Series:Health and Quality of Life Outcomes
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12955-017-0661-5
_version_ 1819077678774353920
author San Keller
Manshu Yang
Marsha J. Treadwell
Kathryn L. Hassell
author_facet San Keller
Manshu Yang
Marsha J. Treadwell
Kathryn L. Hassell
author_sort San Keller
collection DOAJ
description Abstract Background Sickle Cell Disease (SCD) causes profound suffering and decrements in daily functioning. Demand is growing for valid and reliable measures to systematically document these effects, particularly in adults. The Adult Sickle Cell Quality of Life Measurement System, ASCQ-Me℠, was developed for this purpose. ASCQ-Me℠ is one of four measurement systems housed within the Person–Centered Assessment Resource (PCAR), funded by the National Institutes of Health, to support clinical research. To help users select the best of these measures for adults with SCD, we evaluated and compared two PCAR systems: one designed to be “universally applicable” (the Patient-Reported Outcome Measurement Information System, PROMIS®) and one designed specifically for SCD (ASCQ-Me℠). Methods Respondents to PROMIS and ASCQ-Me questions were 490 adults with SCD from seven geographically-disbursed clinics within the US. Data were collected for six ASCQ-Me measures (Emotional Impact, Sleep Impact, Social Impact, Stiffness Impact, Pain Impact, SCD Pain Episode Frequency and Severity) and ten PROMIS measures (Pain Impact, Pain Behavior, Physical Functioning, Anxiety, Depression, Fatigue, Satisfaction with Discretionary Social Activities, Satisfaction with Social Roles, Sleep Disturbance, and Sleep-Related Impairment). Statistical analyses, including analysis of variance and multiple linear regression, were conducted to determine the sensitivity of measures to SCD severity. SCD severity was assessed via a checklist of associated treatments and conditions. Results For those with the most severe SCD, PROMIS scores showed worse health compared to the general population for nine of ten health domains: the magnitude of the difference ranged 0.5 to 1.1 standard deviation units. The PROMIS domains most severely affected were Physical Functioning and Pain (Impact and Behavior). Significant differences by tertile of the SCD-MHC were shown for most PROMIS short forms and all ASCQ-Me short and fixed forms. In most models, ASCQ-Me measures explained statistically significant unique variance in SCD-MHC scores complementary to that explained by corresponding PROMIS measures. Conclusions Study results supported the validity of both PROMIS and ASCQ-Me measures for use in adults with SCD. Compared to comparable PROMIS scores, most ASCQ-Me scores were better predictors of SCD disease severity, as measured by a medical history checklist. The clinical implications of these results require further investigation.
first_indexed 2024-12-21T19:01:01Z
format Article
id doaj.art-a52673d3f1704f1a923c43e797948282
institution Directory Open Access Journal
issn 1477-7525
language English
last_indexed 2024-12-21T19:01:01Z
publishDate 2017-06-01
publisher BMC
record_format Article
series Health and Quality of Life Outcomes
spelling doaj.art-a52673d3f1704f1a923c43e7979482822022-12-21T18:53:29ZengBMCHealth and Quality of Life Outcomes1477-75252017-06-0115111410.1186/s12955-017-0661-5Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠San Keller0Manshu Yang1Marsha J. Treadwell2Kathryn L. Hassell3American Institutes for ResearchAmerican Institutes for ResearchChildren’s Hospital & Research Center OaklandDivision of Hematology, University of ColoradoAbstract Background Sickle Cell Disease (SCD) causes profound suffering and decrements in daily functioning. Demand is growing for valid and reliable measures to systematically document these effects, particularly in adults. The Adult Sickle Cell Quality of Life Measurement System, ASCQ-Me℠, was developed for this purpose. ASCQ-Me℠ is one of four measurement systems housed within the Person–Centered Assessment Resource (PCAR), funded by the National Institutes of Health, to support clinical research. To help users select the best of these measures for adults with SCD, we evaluated and compared two PCAR systems: one designed to be “universally applicable” (the Patient-Reported Outcome Measurement Information System, PROMIS®) and one designed specifically for SCD (ASCQ-Me℠). Methods Respondents to PROMIS and ASCQ-Me questions were 490 adults with SCD from seven geographically-disbursed clinics within the US. Data were collected for six ASCQ-Me measures (Emotional Impact, Sleep Impact, Social Impact, Stiffness Impact, Pain Impact, SCD Pain Episode Frequency and Severity) and ten PROMIS measures (Pain Impact, Pain Behavior, Physical Functioning, Anxiety, Depression, Fatigue, Satisfaction with Discretionary Social Activities, Satisfaction with Social Roles, Sleep Disturbance, and Sleep-Related Impairment). Statistical analyses, including analysis of variance and multiple linear regression, were conducted to determine the sensitivity of measures to SCD severity. SCD severity was assessed via a checklist of associated treatments and conditions. Results For those with the most severe SCD, PROMIS scores showed worse health compared to the general population for nine of ten health domains: the magnitude of the difference ranged 0.5 to 1.1 standard deviation units. The PROMIS domains most severely affected were Physical Functioning and Pain (Impact and Behavior). Significant differences by tertile of the SCD-MHC were shown for most PROMIS short forms and all ASCQ-Me short and fixed forms. In most models, ASCQ-Me measures explained statistically significant unique variance in SCD-MHC scores complementary to that explained by corresponding PROMIS measures. Conclusions Study results supported the validity of both PROMIS and ASCQ-Me measures for use in adults with SCD. Compared to comparable PROMIS scores, most ASCQ-Me scores were better predictors of SCD disease severity, as measured by a medical history checklist. The clinical implications of these results require further investigation.http://link.springer.com/article/10.1186/s12955-017-0661-5ASCQ-Me℠PROMIS®Validity, Sickle cell diseasePatient-reported outcomesItem response theory
spellingShingle San Keller
Manshu Yang
Marsha J. Treadwell
Kathryn L. Hassell
Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠
Health and Quality of Life Outcomes
ASCQ-Me℠
PROMIS®
Validity, Sickle cell disease
Patient-reported outcomes
Item response theory
title Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠
title_full Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠
title_fullStr Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠
title_full_unstemmed Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠
title_short Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠
title_sort sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease comparison of promis r to ascq me℠
topic ASCQ-Me℠
PROMIS®
Validity, Sickle cell disease
Patient-reported outcomes
Item response theory
url http://link.springer.com/article/10.1186/s12955-017-0661-5
work_keys_str_mv AT sankeller sensitivityofalternativemeasuresoffunctioningandwellbeingforadultswithsicklecelldiseasecomparisonofpromistoascqme
AT manshuyang sensitivityofalternativemeasuresoffunctioningandwellbeingforadultswithsicklecelldiseasecomparisonofpromistoascqme
AT marshajtreadwell sensitivityofalternativemeasuresoffunctioningandwellbeingforadultswithsicklecelldiseasecomparisonofpromistoascqme
AT kathrynlhassell sensitivityofalternativemeasuresoffunctioningandwellbeingforadultswithsicklecelldiseasecomparisonofpromistoascqme